Current laboratory practices in the diagnosis and management of haemophilia: a global assessment.
about
The History of Clotting Factor Concentrates PharmacokineticsA critical appraisal of one-stage and chromogenic assays of factor VIII activity.Recombinant to modified factor VIII and factor IX - chromogenic and one-stage assays issues.A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE.Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.A computer-based model to assess costs associated with the use of factor VIII and factor IX one-stage and chromogenic activity assays.Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.Qualification of a select one-stage activated partial thromboplastin time-based clotting assay and two chromogenic assays for the post-administration monitoring of nonacog beta pegol.One-Stage Factor VIII Assays.BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study.Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study.Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8-GP.Educational needs of hematologists and laboratory professionals regarding factor activity assays.
P2860
Q30235127-C5881BFB-CF59-4BD6-AEC4-645478EC66AAQ38668506-1742E7BA-65C0-4E2B-B9CC-E1A8FAA7F30EQ38894174-60A4A240-F799-40BD-88E6-E7EAF1DC230DQ39648285-FFCBE977-008F-49E2-AD63-D52385065EC4Q39898980-A39BCA59-D962-4B3F-9B0F-91D3D5517F07Q45004372-3F73989E-E08A-4B90-8CC7-5C4FC5F24EDBQ45864807-FF012F9C-C742-43B6-A85F-4344A0D33FBFQ45867048-2F0E1F4C-2189-4376-A680-B7F5D93B818BQ45870406-AE8EDCF2-6EFB-47D9-BAC9-AFC6F1E6A2D6Q45870711-1CED1A6D-08E4-4DCA-9273-6580121447E8Q45884519-78F81EDF-483D-4046-8245-E0F49404B646Q45885298-1CEE45D2-A58E-4D75-A532-DAF16DB4291BQ45887366-B3D3B457-1A29-4C55-BAC0-F3E44234ED74Q45887550-0A2208BC-17DD-4FD4-AFA1-8879BFCDB9CBQ55113451-A29DDDD6-0AB9-4C86-94FF-9FFA17B5E454
P2860
Current laboratory practices in the diagnosis and management of haemophilia: a global assessment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Current laboratory practices i ...... mophilia: a global assessment.
@en
Current laboratory practices i ...... mophilia: a global assessment.
@nl
type
label
Current laboratory practices i ...... mophilia: a global assessment.
@en
Current laboratory practices i ...... mophilia: a global assessment.
@nl
prefLabel
Current laboratory practices i ...... mophilia: a global assessment.
@en
Current laboratory practices i ...... mophilia: a global assessment.
@nl
P2093
P2860
P356
P1433
P1476
Current laboratory practices i ...... mophilia: a global assessment.
@en
P2093
K Signer-Romero
P2860
P304
P356
10.1111/HAE.12639
P577
2015-02-16T00:00:00Z